ASX:CGS Cogstate (CGS) Stock Price, News & Analysis → Elon to Transform U.S. Economy? (From Porter & Company) (Ad) Free CGS Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume2,002 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend Yield10.53%Price TargetN/A Stock AnalysisStock Analysis Get Cogstate alerts: Email Address Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now About Cogstate Stock (ASX:CGS)Cogstate Limited, a neuroscience technology company, engages in the creation, validation, and commercialization of digital brain health assessments used in both academic and industry sponsored research. Its cognitive services include project management, data management, scientific consulting, statistical analysis, scales procurement, rater training, and monitoring solutions. The company is also involved in the design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments. Its technology and associated services are used to quantify the effect of diseases and drugs, and devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. The company also provides Cognigram, a system for regular and standardized testing to assist primary care physicians and/or hospitals in the early detection of cognitive decline. As of June 30, 2023, it had participated in approximately 1,800 academic research studies and 530 industry sponsored clinical trials. Cogstate Limited was incorporated in 1999 and is based in Melbourne, Australia.Read More Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now CGS Stock News HeadlinesApril 14, 2024 | finance.yahoo.comCogstate (ASX:CGS) shareholders have earned a 42% CAGR over the last five yearsFebruary 22, 2024 | msn.comASX Health Stocks: Cogstate falls as pipeline contracts; LBT delivers product to Thermo FisherMay 4, 2024 | Stansberry Research (Ad)Global crypto currency reset (41 major banks signed up)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project...February 16, 2024 | finance.yahoo.comAre Cogstate Limited's (ASX:CGS) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?December 20, 2023 | finance.yahoo.comBullish Cogstate Insiders Loaded Up On US$4.47m Of StockNovember 1, 2023 | finance.yahoo.comInvesting in Cogstate (ASX:CGS) five years ago would have delivered you a 121% gainOctober 18, 2023 | finance.yahoo.comShareholders Will Probably Hold Off On Increasing Cogstate Limited's (ASX:CGS) CEO Compensation For The Time BeingSeptember 26, 2023 | finance.yahoo.comWith a 49% stake, Cogstate Limited (ASX:CGS) insiders have a lot riding on the companyMay 4, 2024 | Stansberry Research (Ad)Global crypto currency reset (41 major banks signed up)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project...September 9, 2023 | finance.yahoo.comDeclining Stock and Decent Financials: Is The Market Wrong About Cogstate Limited (ASX:CGS)?August 23, 2023 | finance.yahoo.comResults: Cogstate Limited Exceeded Expectations And The Consensus Has Updated Its EstimatesJuly 13, 2023 | finance.yahoo.comBullish Cogstate Insiders Loaded Up On US$4.5m Of StockJune 6, 2023 | finance.yahoo.comCogstate Limited's (ASX:CGS) Intrinsic Value Is Potentially 40% Above Its Share PriceMay 15, 2023 | finance.yahoo.comInvestors in Cogstate (ASX:CGS) have seen incredible returns of 404% over the past three yearsMay 10, 2023 | msn.comMoneyTalks: Why Aeris Resources and Cogstate are firmly on brokers’ Buy listApril 22, 2023 | msn.comBELL POTTER SECURITIES Maintains COGSTATE (ASX:CGS) Buy RecommendationApril 6, 2023 | finance.yahoo.comRetail investors account for 38% of Cogstate Limited's (ASX:CGS) ownership, while institutions account for 34%March 23, 2023 | finance.yahoo.comNeed To Know: Analysts Are Much More Bullish On Cogstate Limited (ASX:CGS) RevenuesMarch 19, 2023 | finance.yahoo.comCogstate Limited's (ASX:CGS) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?March 4, 2023 | finance.yahoo.comCogstate Limited (ASX:CGS) Analysts Just Slashed This Year's EstimatesFebruary 21, 2023 | finance.yahoo.comHere's Why We Think Cogstate (ASX:CGS) Is Well Worth WatchingFebruary 18, 2023 | afr.comCogstate LimitedFebruary 3, 2023 | finance.yahoo.comTrade Alert: David Dolby At Cogstate Limited (ASX:CGS), Has Just Spent US$4.3m Buying 9.3% More SharesJanuary 15, 2023 | finance.yahoo.comUnder The Bonnet, Cogstate's (ASX:CGS) Returns Look ImpressiveDecember 4, 2022 | finance.yahoo.comCogstate's (ASX:CGS) investors will be pleased with their massive 477% return over the last three yearsDecember 1, 2022 | finance.yahoo.comCogstate Limited (CGS.AX)October 9, 2022 | finance.yahoo.comAre Robust Financials Driving The Recent Rally In Cogstate Limited's (ASX:CGS) Stock?See More Headlines Receive CGS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cogstate and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Health Information Services Sub-IndustryN/A Current SymbolASX:CGS CUSIPN/A CIKN/A Webwww.cogstate.com Phone61 3 9664 1300FaxN/AEmployees158Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A$0.05 Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$5.51 million Net Margins13.42% Pretax MarginN/A Return on Equity15.37% Return on Assets4.77% Debt Debt-to-Equity Ratio1.37 Current Ratio3.24 Quick Ratio2.24 Sales & Book Value Annual Sales$41.08 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow7.79 Book ValueA$0.22 per share Price / BookN/AMiscellaneous Outstanding Shares171,420,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta0.13 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesMr. Bradley John O'Connor B.BusC.A., CA, CEO, MD & Executive DirectorProf. Paul Maruff BBSc (Hons)Ph.D., Founder & Chief Innovation OfficerMr. Darren WatsonChief Financial OfficerMr. Benjamin BloomfieldChief Technology OfficerDr. Chris Edgar Ph.D.Chief Science OfficerMr. Kenneth BillardChief Commercial OfficerMs. Rachel ColiteExecutive VP of Clinical TrialsMs. Kristi GeddesGeneral Counsel, Joint Company Secretary & DirectorMr. David James Franks BEc (Age 54)C.A., F Fin, J.P., Joint Company Secretary More ExecutivesKey Competitors1st GroupASX:1STAclarionNASDAQ:ACONWAlcidion GroupASX:ALCArcturis DataOTCMKTS:SSYNFArtryaASX:AYAView All CompetitorsInsidersRichard MohsBought 12,000 shares on 5/16/2023Total: $20,640.00 ($1.72/share) This page (ASX:CGS) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchAutomatic Income (from home)Awesomely, LLCFW: 234x GainWeiss RatingsCould Your Accounts Be Frozen?Allegiance GoldThe Gold Grab of the CenturyColonial MetalsStock-Picking AI Predicts #1 Stock of 2024Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cogstate Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.